Evidence map›Paper›PMID 32422882›Full record

ReviewMolecules (Basel, Switzerland)2020

Effects of Vitamin D Supplementation on Inflammation, Colonic Cell Kinetics, and Microbiota in Colitis: A Review.

Patricia Mae Garcia, Jeff Moore, David Kahan, Mee Young Hong

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Effects of Commercial Probiotics on Colonic Sensitivity after Acute Mucosal Irritation.International journal of environmental research and public health · 2022
    Article
  10. Vitamin DFrontiers in nutrition · 2022
    Article
  11. Vitamin D and Microbiota: Is There a Link with Allergies?International journal of molecular sciences · 2021
    Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Patricia Mae GarciaSchool of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA 92182, USA.
Jeff MooreSchool of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA 92182, USA.ORCID 0000-0002-8867-6632
David KahanSchool of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA 92182, USA.ORCID 0000-0002-3135-2215
Mee Young HongSchool of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA 92182, USA.ORCID 0000-0003-1262-0074
San Diego State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin D is widely known to regulate bone health, but there is increasing evidence that it may also ameliorate colitis through inflammation, cell proliferation and apoptosis, and the microbiota. The purpose of this review is to systematically examine the mechanisms by which vitamin D reduces colitis. PubMed and Web of Science were searched for articles published between 2008 and 2019 using key words such as "vitamin D," "colitis," "inflammatory bowel disease," "inflammation," "apoptosis," "cell proliferation," and "gut bacteria". Retrieved articles were further narrowed and it was determined whether their title and abstracts contained terminology pertaining to vitamin D in relation to colitis in human clinical trials, animal studies, and cell culture/biopsy studies, as well as selecting the best match sorting option in relation to the research question. In total, 30 studies met the established criteria. Studies consistently reported results showing that vitamin D supplementation can downregulate inflammatory pathways of COX-2, TNF-α, NF-κB, and MAPK, modify cell kinetics, and alter gut microbiome, all of which contribute to an improved state of colitis. Although vitamin D and vitamin D analogs have demonstrated positive effects against colitis, more randomized, controlled human clinical trials are needed to determine the value of vitamin D as a therapeutic agent in the treatment of colitis.

Indexed as

Dietary SupplementsAnimalsClinical Trials as TopicColitisColonCyclooxygenase 2Epithelial CellsGastrointestinal MicrobiomeGene Expression RegulationHumansInflammationInflammatory Bowel DiseasesMiceMitogen-Activated Protein KinasesNF-kappa BSignal TransductionCyclooxygenase 2Mitogen-Activated Protein KinasesNF-kappa BPTGS2 protein, humanTumor Necrosis Factor-alphaVitamin Dcell kineticsgut microbiomeinflammationinflammatory bowel diseasevitamin D

Identifiers

PMID32422882
PMCPMC7288056
OpenAlexW3025726988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.